Changes in ischemic stroke presentations and associated workflow during the first wave of the COVID-19 pandemic: A population study in Alberta, Canada
Ganesh, A.; Stang, J. M.; McAlister, F.; Shlakhter, O.; Holodinsky, J. K.; Mann, B.; Hill, M. D.; Smith, E. E.
Show abstract
BackgroundPandemics may promote hospital avoidance among patients with emergencies, and added precautions may exacerbate treatment delays. There is a paucity of population-based data on these phenomena for stroke. We examined the effect of the COVID-19 pandemic on the presentation and treatment of ischemic stroke in an entire population. MethodsWe used linked provincial administrative data and data from the Quality Improvement and Clinical Research Alberta Stroke Program - a registry capturing stroke-related data on the entire population of Alberta(4.3 million)- to identify all patients presenting with stroke in the pre-pandemic(1-January-2016 to 27-February-2020, n=19,531) and pandemic(28-February-2020 to 30-August-2020, n=2,255) periods. We examined changes in thrombolysis and endovascular therapy(EVT) rates, workflow, and in-hospital outcomes. ResultsHospitalizations/presentations for ischemic stroke dropped (weekly adjusted-incidence-rate-ratio[aIRR]:0.48, 95%CI:0.46-0.50, adjusted for age, sex, comorbidities, pre-admission care needs), as did population-level incidence of thrombolysis(aIRR:0.49,0.44-0.56) or EVT(aIRR:0.59,0.49-0.69). However, the proportions of presenting patients receiving acute therapies did not decline (e.g. thrombolysis:11.7% pre-pandemic vs 13.1% during-pandemic, aOR:1.02,0.75-1.38). Onset-to-door times were prolonged; EVT recipients experienced longer door-to-reperfusion times (median door-to-reperfusion:110-minutes, IQR:77-156 pre-pandemic vs 132.5-minutes, 99-179 during-pandemic; adjusted-coefficient:18.7-minutes, 95%CI:1.45-36.0). Hospitalizations were shorter but stroke severity and in-hospital mortality did not differ. InterpretationThe first COVID-19 wave was associated with a halving of presentations and acute therapy utilization for ischemic stroke at a population level, and greater pre-hospital and in-hospital treatment delays. Our data can inform public health messaging and stroke care in current and future waves. Messaging should encourage attendance for emergencies and stroke systems should re-examine "code stroke" protocols to mitigate inefficiencies.
Matching journals
The top 3 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Prospective Observational Cohort Study Of Tenecteplase Versus Alteplase In Routine Clinical Practice 96%
- Risk, clinical course and outcome of ischemic stroke in patients hospitalized with COVID-19: a multicenter cohort study 95%
- Effect of Time to Thrombolysis on Clinical Outcomes in Patients with Acute Ischemic Stroke Treated with Tenecteplase Compared to Alteplase: Analysis from the AcT Randomized Controlled Trial 95%
Similar papers in this journal
- COVID-19 Infection Is Associated with Poor Outcomes in Patients with Intracerebral Hemorrhage 96%
- Disparities in Access to Vascular Stroke Imaging and Carotid Revascularization: A Population Study 96%
- Persistent Inequities in Intravenous Thrombolysis for Acute Ischemic Stroke in the U.S.: Results from the NIS 95%
Similar papers in this journal
- Modified Rankin Scale Disability Status at Day 4 Poststroke is an Informative Predictor of Long-Term Day 90 Outcome 95%
- Documented Goals of Care Conversations with Hospitalized Patients after Severe Stroke 93%
- Vascular Risk Factor Prevalence and Trends in Native Americans With Ischemic Stroke - A National Inpatient Sample Analysis 93%
Similar papers in this journal
- Prehospital triage of intracranial hemorrhage and anterior large vessel occlusion ischemic stroke: the value of the rapid arterial occlusion evalution 96%
- Large Core Thrombectomy: Feasibility Of Simplified Protocol In Resource-Limited Settings 94%
- Adjunctive Intra-arterial Urokinase after Successful Endovascular Thrombectomy in Patients with Large Vessel Occlusion Stroke (POST-UK): Study protocol of a multicenter, prospective, randomized, open-label, blinded-endpoint trial 93%
Similar papers in this journal
- Workflow Intervals andOutcomesof Endovascular Treatment for Acute Large-Vessel Occlusion During On- Versus Off-Hours in China The ANGEL-ACT Registry 94%
- Factors Associated with Stroke after COVID-19 Vaccination: A Statewide Analysis 94%
- Endovascular thrombectomy: an effective and safe therapy for perioperative ischemic stroke 92%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.